TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Trinity Biotech ( (TRIB) ).
On November 18, 2025, Trinity Biotech announced it received World Health Organization approval for the offshored and outsourced manufacturing of its Uni-Gold rapid HIV test. This approval is a significant milestone in the company’s transformation plan aimed at enhancing profitability. The strategic move to offshore manufacturing is expected to improve gross margins, EBITDA, and cash flow, while maintaining product integrity and compliance. This initiative reflects the leadership’s capability to execute strategic transformations and positions the company for long-term growth by reducing costs and focusing on innovation.
The most recent analyst rating on (TRIB) stock is a Sell with a $1.00 price target. To see the full list of analyst forecasts on Trinity Biotech stock, see the TRIB Stock Forecast page.
Spark’s Take on TRIB Stock
According to Spark, TipRanks’ AI Analyst, TRIB is a Underperform.
Trinity Biotech’s overall stock score is primarily impacted by its weak financial performance, characterized by declining revenues and profitability, high debt levels, and negative equity. Technical analysis indicates bearish momentum, further weighing on the stock’s outlook. The negative P/E ratio and lack of dividend yield contribute to a poor valuation score, reinforcing the need for strategic improvements to enhance financial stability and investor confidence.
To see Spark’s full report on TRIB stock, click here.
More about Trinity Biotech
Trinity Biotech is a commercial-stage biotechnology company specializing in diabetes management solutions and human diagnostics, including wearable biosensors. The company develops, acquires, manufactures, and markets diagnostic systems for point-of-care and clinical laboratory segments, and has recently expanded into the wearable biosensor industry. Trinity Biotech’s products are used for detecting infectious diseases and measuring various chemistry parameters in blood, and are distributed in over 75 countries worldwide.
Average Trading Volume: 155,464
Technical Sentiment Signal: Strong Sell
Current Market Cap: $15.21M
See more insights into TRIB stock on TipRanks’ Stock Analysis page.